RSS Feeds
Search

Deals review

SCOLR Pharma, Inc. Signs Agreement with The Emerson Group to Provide Sales Support for Nutritional & OTC Products

In order to access this content you must be logged in and have a subscription to Pharmalicensing Intelligence.

Pharmalicensing Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.

Subscribe now for instant access to the benefits Pharmalicensing Intelligence has to offer. Find out more.

Related deals

SCOLR Pharma and Perrigo announce strategic alliance to manufacture and market CDT(R) nutritional products

SCOLR Pharma, Inc. Announces New Product Launch with Alliance Partner

SCOLR Pharma Secures Contract Manufacturer for Pseudoephedrine Tablets for Use in Q1 '05 Human Trials

SCOLR Pharma Secures Contract Manufacturer for Raloxifene Tablets to Use in Q2 '05 Human Trials

SCOLR Pharma Announces Research Collaboration with BioCryst Pharmaceuticals

SCOLR Pharma, Inc. and Dr. Reddy’s Laboratories Enter into Collaboration and License Agreement

SCOLR Pharma, Inc. Enters into Worldwide Licensing Agreement with RedHill Biopharma Ltd.

SCOLR Pharma secures contract manufacturer for 24 hour CDT Pseudoephedrine tablets

Omega Pharma acquires OTC organisations

Natrol, Inc. Enters into Joint Venture for China

More deals

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us